Related Experiment Videos
Heating system with a lens applicator for 430 MHz microwave hyperthermia
Y Nikawa1, M Kikuchi, T Terakawa
1Department of Electrical Engineering, National Defense Academy, Yokosuka, Japan.
Summary
This study introduces a novel microwave applicator for hyperthermia cancer treatment, achieving deeper and more precise heating. The system demonstrates stable temperature control, indicating its clinical potential for effective tumor therapy.
Area of Science:
- Biomedical Engineering
- Electromagnetics
- Oncology
Background:
- Hyperthermia treatment for cancer requires deep and localized heating.
- Conventional microwave applicators have limitations in heating depth and precision.
- Development of advanced applicators is crucial for effective cancer therapy.
Purpose of the Study:
- To develop and evaluate a computer-controlled microwave electromagnetic (EM) heating system for hyperthermia cancer treatment.
- To investigate the heating capabilities of a novel metal plate lens applicator operating at 430 MHz.
- To assess the system's precision and stability for clinical applications.
Main Methods:
- Design and implementation of a 430 MHz metal plate lens applicator.
- Calculation of electric-field distribution within a lossy medium (saline solution phantom).
- Conducting heating experiments on a saline phantom to measure heating depth and temperature stability.
- Development of a computer-controlled system for precise temperature regulation.
Main Results:
- The lens applicator achieved a maximum heating depth exceeding 60 mm, twice that of conventional waveguide applicators.
- Experimental heating depths closely matched theoretical calculations.
- The computer-controlled system maintained temperature fluctuations within +/- 0.3 degrees C in the heating region.
Conclusions:
- The developed metal plate lens applicator system enables deep and localized microwave hyperthermia.
- The system demonstrates high precision and temperature stability, suitable for clinical use.
- This technology holds significant promise for advancing clinical hyperthermia cancer treatment.